GUNZE Medical USA https://validator.w3.org/feed/docs/rss2.html Home PELNAC®/THERAGENESIS® Join Gunze at AATS 2026 Join Gunze at FILACP Panama 2026 Join Gunze at AHPBA 2026 Annual Meeting Join Gunze at SSO 2026 Annual Meeting Join Gunze at Hospitalar 2026 Join Gunze at 80th Annual Meeting of the ASSH Gunze’s U.S. Medical Division NEOVEIL® Staple Line Reinforcement Join Gunze at ACS Clinical Congress 2025 Join Gunze at WHX Miami 2025 OEM Join Gunze at AATS 2025 History OEM Privacy Policy Gunze Launches TENALEAF™ Absorbable Adhesion Barrier in Japan<br>tailored to medical professionals to improve patient clinical outcome PELNAC® Bilayer Wound Matrix Receives U.S. Food and Drug Administration (FDA) Clearance Gunze Enters into Exclusive Supply and Distribution Agreement with Misonix for TheraGenesis® Bilayer Wound Matrix in U.S. Market Announcing the use of Gunze’s meniscal repair biodegradable scaffolds for a clinical trial to improve the outcome of medial meniscal injury patients at Osaka Medical and Pharmaceutical University Launch of Gunze’s U.S. Medical Division Website R&D Terms of Service Products Outside The U.S. Future Launches Gunze provides biodegradable scaffolds for TEVG clinical trial to be conducted at the Abigail Wexner Research Institute at Nationwide Children’s Hospital to improve pediatric patient clinical outcome News About Us Solutions Sample Page Contact